Literature DB >> 19617628

Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.

Nareen Abboud1, Magdia De Jesus, Antonio Nakouzi, Radames J B Cordero, Mario Pujato, András Fiser, Johanna Rivera, Arturo Casadevall.   

Abstract

Protective antigen (PA), the binding subunit of anthrax toxin, is the major component in the current anthrax vaccine, but the fine antigenic structure of PA is not well defined. To identify linear neutralizing epitopes of PA, 145 overlapping peptides covering the entire sequence of the protein were synthesized. Six monoclonal antibodies (mAbs) and antisera from mice specific for PA were tested for their reactivity to the peptides by enzyme-linked immunosorbent assays. Three major linear immunodominant B-cell epitopes were mapped to residues Leu(156) to Ser(170), Val(196) to Ile(210), and Ser(312) to Asn(326) of the PA protein. Two mAbs with toxin-neutralizing activity recognized two different epitopes in close proximity to the furin cleavage site in domain 1. The three-dimensional complex structure of PA and its neutralizing mAbs 7.5G and 19D9 were modeled using the molecular docking method providing models for the interacting epitope and paratope residues. For both mAbs, LeTx neutralization was associated with interference with furin cleavage, but they differed in effectiveness depending on whether they bound on the N- or C-terminal aspect of the cleaved products. The two peptides containing these epitopes that include amino acids Leu(156)-Ser(170) and Val(196)-Ile(210) were immunogenic and elicited neutralizing antibody responses to PA. These results identify the first linear neutralizing epitopes of PA and show that peptides containing epitope sequences can elicit neutralizing antibody responses, a finding that could be exploited for vaccine design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617628      PMCID: PMC2757211          DOI: 10.1074/jbc.M109.022061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Multiple mapping method: a novel approach to the sequence-to-structure alignment problem in comparative protein structure modeling.

Authors:  Brajesh K Rai; András Fiser
Journal:  Proteins       Date:  2006-05-15

2.  PA63 channel of anthrax toxin: an extended beta-barrel.

Authors:  Shilla Nassi; R John Collier; Alan Finkelstein
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

3.  A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection.

Authors:  Helen C Flick-Smith; Nicola J Walker; Paula Gibson; Helen Bullifent; Sarah Hayward; Julie Miller; Richard W Titball; E Diane Williamson
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 4.  Anthrax toxins: A paradigm of bacterial immune suppression.

Authors:  Cosima T Baldari; Fiorella Tonello; Silvia Rossi Paccani; Cesare Montecucco
Journal:  Trends Immunol       Date:  2006-07-24       Impact factor: 16.687

5.  Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Authors:  Magdia De Jesus; André Moraes Nicola; Marcio L Rodrigues; Guilhem Janbon; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2008-10-24

6.  Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Authors:  Johnny W Peterson; Jason E Comer; Wallace B Baze; David M Noffsinger; Autumn Wenglikowski; Kristin G Walberg; Jason Hardcastle; Jennifer Pawlik; Kathryn Bush; Joanna Taormina; Scott Moen; John Thomas; Bagram M Chatuev; Laurie Sower; Ashok K Chopra; Lawrence R Stanberry; Ritsuko Sawada; Wolfgang W Scholz; Jagadish Sircar
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

7.  Anthrax protective antigen cleavage and clearance from the blood of mice and rats.

Authors:  Mahtab Moayeri; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

8.  Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.

Authors:  Nareen Abboud; Arturo Casadevall
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

9.  The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.

Authors:  Jun Zhang; Junjie Xu; Guanlin Li; Dayong Dong; Xiaohong Song; Qiang Guo; Jian Zhao; Ling Fu; Wei Chen
Journal:  Biochem Biophys Res Commun       Date:  2006-01-26       Impact factor: 3.575

10.  Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.

Authors:  Michael J Gubbins; Jody D Berry; Cindi R Corbett; Jeremy Mogridge; Xin Y Yuan; Lisa Schmidt; Brigitte Nicolas; Amin Kabani; Raymond S Tsang
Journal:  FEMS Immunol Med Microbiol       Date:  2006-08
View more
  26 in total

1.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.

Authors:  William A Langley; Konrad C Bradley; Zhu-Nan Li; Mary Ellen Smith; Matthias J Schnell; David A Steinhauer
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

4.  Host membrane glycosphingolipids and lipid microdomains facilitate Histoplasma capsulatum internalisation by macrophages.

Authors:  Allan J Guimarães; Mariana Duarte de Cerqueira; Daniel Zamith-Miranda; Pablo H Lopez; Marcio L Rodrigues; Bruno Pontes; Nathan B Viana; Carlos M DeLeon-Rodriguez; Diego Conrado Pereira Rossi; Arturo Casadevall; Andre M O Gomes; Luis R Martinez; Ronald L Schnaar; Joshua D Nosanchuk; Leonardo Nimrichter
Journal:  Cell Microbiol       Date:  2018-12-07       Impact factor: 3.715

Review 5.  Immunity to ricin: fundamental insights into toxin-antibody interactions.

Authors:  Joanne M O'Hara; Anastasiya Yermakova; Nicholas J Mantis
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein.

Authors:  Martha Sedegah; Yohan Kim; Bjoern Peters; Shannon McGrath; Harini Ganeshan; Jennylynn Lejano; Esteban Abot; Glenna Banania; Maria Belmonte; Renato Sayo; Fouzia Farooq; Denise L Doolan; David Regis; Cindy Tamminga; Ilin Chuang; Joseph T Bruder; C Richter King; Christian F Ockenhouse; Bart Faber; Edmond Remarque; Michael R Hollingdale; Thomas L Richie; Alessandro Sette
Journal:  Malar J       Date:  2010-08-24       Impact factor: 2.979

7.  Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax.

Authors:  Johanna Rivera; Antonio S Nakouzi; Alfred Morgenstern; Frank Bruchertseifer; Ekaterina Dadachova; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

8.  Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies.

Authors:  Siu-Kei Chow; Cameron Smith; Thomas MacCarthy; Mary Ann Pohl; Aviv Bergman; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

9.  Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.

Authors:  Mary Ann Pohl; Johanna Rivera; Antonio Nakouzi; Siu-Kei Chow; Arturo Casadevall
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

10.  Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model.

Authors:  Joseph Jelinski; Austen Terwilliger; Sabrina Green; Anthony Maresso
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.